MedPath

Study of Emu Oil vs. Placebo for Vulvar Pain in Women.

Not Applicable
Terminated
Conditions
Vulvodynia
Vestibulodynia
Interventions
Other: Emu Oil
Other: Inert oil
Registration Number
NCT01295268
Lead Sponsor
William Beaumont Hospitals
Brief Summary

The goal of this study is to determine if vulvar (external female genitalia) pain is decreased with emu oil over a similar placebo oil (no active ingredient) by using measurement devices, examinations, and questionnaires. Topical emu oil has not been scientifically studied for this condition yet, but related reports show no significant side effects or potential benefits.

A total of 30 women will participate in the study at William Beaumont Hospital, Royal Oak.

Detailed Description

* Women of all ages with vulvar pain may participate in this trial.

* Women will be randomized into 2 groups--a treatment group or placebo group for the 1 month study.

* At the end of the study, those in the placebo group may choose to participate in a 1 month follow-up evaluation using emu oil.

Recruitment & Eligibility

Status
TERMINATED
Sex
Female
Target Recruitment
1
Inclusion Criteria
  • Women with vulvar pain upon q-tip exam of > 3/10 at 2 or more sites tested.
  • Age 18 or older.
  • Capable of giving informed consent.
  • Capable and willing to follow all study procedures.
Exclusion Criteria
  • Pregnant women or those intending to become pregnant during the study period.
  • Vaginitis (may be treated, then tested later).
  • Vulvar disease (other than vulvodynia)-lichen planus, lichen sclerosis, neoplasia, tissue damage due to radiation.
  • The subject is deemed unsuitable for enrollment by the investigators based on their history or physical examination.
  • Neuropathy.
  • Currently in pelvic floor physical therapy.

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Emu OilEmu Oil-
inert oilInert oil-
Primary Outcome Measures
NameTimeMethod
The change in the Global Response Assessment (GRA) for vulvar pain.After 1 month of intervention

Those "moderately" or "markedly" improved on the GRA are responders

Secondary Outcome Measures
NameTimeMethod
The change in vulvar pain levelsAfter 1 month of intervention

Based on a pain visual analog scale (VAS) and vulvalgesiometer evaluations.

Trial Locations

Locations (1)

Beaumont Women's Urology Center

🇺🇸

Royal Oak, Michigan, United States

© Copyright 2025. All Rights Reserved by MedPath